Clinical Trial Update: Seroquel- Agitation Associated With Dementia [Phase 3]

View source ↗

Summary

Phase 3 trial of quetiapine (Seroquel) for agitation in Alzheimer's disease and vascular dementia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Vascular Dementia

Drugs mentioned

• SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Alzheimer's Disease, Vascular Dementia | Phase 3 | Status: COMPLETED